Literature DB >> 3546516

Patterns of antibody response in individuals infected with the human immunodeficiency virus.

L Z Pan, C Cheng-Mayer, J A Levy.   

Abstract

Immunofluorescence and immunoblot assays were conducted on 488 sera from patients with AIDS and clinically healthy individuals at risk for infection by the human immunodeficiency virus. Of these, 360 contained antiviral antibodies, and nearly all reacted with the envelope precursor glycoprotein gp160. Sera from 103 individuals for whom a complete clinical history was available were evaluated in detail. Most sera recognized both the gp160 and the p55 gag precursor protein. Because these two antigens are found primarily in infected cells, the results suggest that this association makes them more immunogenic. A high prevalence of antibodies to the polymerase gene products (p65 and p31) and to a viral protein p48, which is not yet fully defined, was also noted. Many sera, particularly those from patients with Kaposi's sarcoma or Pneumocystis carinii pneumonia, lacked antibodies to both p25 and gp41. These antibody patterns could help predict the prognosis for virus-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546516     DOI: 10.1093/infdis/155.4.626

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.

Authors:  C Cheng-Mayer; C Weiss; D Seto; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells.

Authors:  M Tateno; F Gonzalez-Scarano; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Performance and reliability of five commercial enzyme-linked immunosorbent assay kits in screening for anti-human immunodeficiency virus antibody in high-risk subjects.

Authors:  G Ozanne; M Fauvel
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

Review 5.  Practical diagnostic testing for human immunodeficiency virus.

Authors:  J B Jackson; H H Balfour
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

6.  Nuclear localization of foamy virus Gag precursor protein.

Authors:  A W Schliephake; A Rethwilm
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Immunofluorescence assay for human immunodeficiency virus antibody: investigation of cell fixation for virus inactivation and antigen preservation.

Authors:  M Fauvel; G Ozanne
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

8.  Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.

Authors:  B A Castro; C D Weiss; L D Wiviott; J A Levy
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

9.  Microculture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells.

Authors:  D H Dimitrov; J L Melnick; F B Hollinger
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

10.  [Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients].

Authors:  C Schulte; M Meurer; O Braun-Falco; M Held; M Fröschl
Journal:  Klin Wochenschr       Date:  1988-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.